{"id":10090,"date":"2026-09-30T09:24:04","date_gmt":"2026-09-30T09:24:04","guid":{"rendered":"https:\/\/godshand.link\/ground_post\/who-drug-information-volume-40-no-3\/"},"modified":"2026-09-30T09:24:04","modified_gmt":"2026-09-30T09:24:04","slug":"who-drug-information-volume-40-no-3","status":"publish","type":"ground_post","link":"https:\/\/godshand.link\/en_gb\/ground_post\/who-drug-information-volume-40-no-3\/","title":{"rendered":"WHO Drug Information &#8211; Volume 40, No. 3"},"content":{"rendered":"<p><br \/>\n<\/p>\n<section class=\"dynamic-content__section dynamic-content__container\">\n<div class=\"dynamic-content__section-container\">\n<div class=\"dynamic-content__figure-container\">\n<figure class=\"dynamic-content__figure\">\n      <img decoding=\"async\" src=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/f792c156-5650-43de-8729-80af614ba2f2\/content\" alt=\"WHO Drug Information - Volume 40, No. 3\"><br \/>\n     <\/figure>\n<div class=\"button button-blue-background\"><a target=\"_blank\" href=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/0b3f4ea3-ae82-451b-bf5f-bed273c5e3f9\/content\" onclick=\"sendGaEvent('Download','https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/0b3f4ea3-ae82-451b-bf5f-bed273c5e3f9\/content')\">Download <span>(10.2 MB)<\/span><\/a><\/div><\/div>\n<div class=\"dynamic-content__description-container\">\n<div class=\"row\">\n<div class=\"col-md-8\">\n<div class=\"dynamic-content__description\">\n<h3>Overview <\/h3>\n<p>This issue of WHO Drug Information presents Recommended International Nonproprietary Names (INN) List No. 96 for pharmaceutical substances. The names have been selected by the World Health Organization in accordance with the Procedure for the Selection of Recommended International Nonproprietary Names for Pharmaceutical Substances. Inclusion of a name in the list does not imply any recommendation by WHO concerning the use of the corresponding substance in medicine or pharmacy.\n<\/p>\n<p>The publication provides the recommended INN in Latin, English, French and Spanish and, for each substance, presents relevant identification and characterization information, including the chemical name or description, molecular formula and graphic formula, where applicable. By establishing internationally recognized nonproprietary names for pharmaceutical substances, the list forms part of WHO\u2019s continuing INN documentation and provides the latest set of names selected through the established WHO procedure.<\/p>\n<\/p><\/div><\/div>\n<div class=\"col-md-4\">\n<div class=\"dynamic-content__details\">\n<div class=\"detail who-team\">\n<div class=\"label\">WHO Team<\/div>\n<div class=\"value\">\n                 <span><br \/>\nHealth Systems, Access and Data (HSD),                  <\/span><br \/>\n                 <span><br \/>\nMedicines and Health Products, Policies and Standards (HPS),                  <\/span><br \/>\n                 <span><br \/>\nRegulation and Prequalification (RPQ)                 <\/span>\n         <\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Editors<\/div>\n<div class=\"value\">World Health Organization<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Number of pages<\/div>\n<div class=\"value\">242<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Reference numbers<\/div>\n<div class=\"value\">\n<div><strong class=\"label-sm\">ISBN: <\/strong><span>9789240125285<\/span><\/div><\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Copyright<\/div>\n<p>                <a target=\"_blank\" class=\"creativecommons-icons-wrappers\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/igo\/deed.en\" rel=\"license\" title=\"Click here to see the details of CC BY-NC-SA 3.0 IGO\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/cc.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/by.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/nc.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/sa.svg\"><br \/>\n                <\/a>\n        <\/div><\/div><\/div><\/div><\/div><\/div>\n<\/section>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240125285?rand=6398\" target=\"_blank\">Source link <\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Download (10.2 MB) Overview This issue of WHO Drug Information presents Recommended International Nonproprietary Names (INN) List No. 96 for pharmaceutical substances. The names have been selected by the World Health Organization in accordance with the Procedure for the Selection of Recommended International Nonproprietary Names for Pharmaceutical Substances. Inclusion of a name in the list does not imply any recommendation&hellip;<\/p>","protected":false},"author":99035,"featured_media":10091,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":{"give_campaign_id":0,"footnotes":""},"tags":[1572,1270,1573],"ground_category":[315,316],"class_list":["post-10090","ground_post","type-ground_post","status-publish","format-standard","has-post-thumbnail","hentry","tag-drug","tag-information","tag-volume","ground_category-2-grounds-tribulation","ground_category-2-1-time-disease"],"fifu_image_url":"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/f792c156-5650-43de-8729-80af614ba2f2\/content","_links":{"self":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/10090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post"}],"about":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/types\/ground_post"}],"author":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/users\/99035"}],"replies":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/comments?post=10090"}],"version-history":[{"count":0,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/10090\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media\/10091"}],"wp:attachment":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media?parent=10090"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/tags?post=10090"},{"taxonomy":"ground_category","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_category?post=10090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}